Article
PAX3-FOXO1 drives targetable cell state-dependent metabolic vulnerabilities in…
medRxiv · 2025 · Paras, K.; Brunner, J.; Boyer, J. A.; Montero, A.; Jackson, B.; Chakraborty, S.; Xie, A.; Guillan, K.; Siddiquee, A.; Torres, L. P.; Rabinowitz, J.; Kung, A. L.; Dela Cruz, F. S.; Finley, L.
Key facts
| Title | PAX3-FOXO1 drives targetable cell state-dependent metabolic vulnerabilities in rhabdomyosarcoma |
|---|---|
| First author | Paras, K.; Brunner, J.; Boyer, J. A.; Montero, A.; Jackson, B.; Chakraborty, S.; Xie, A.; Guillan, K.; Siddiquee, A.; Torres, L. P.; Rabinowitz, J.; Kung, A. L.; Dela Cruz, F. S.; Finley, L. |
| Journal | medRxiv |
| Published | Jan 1, 2025 |
| DOI | 10.1101/2025.01.15.633227 |
| Devices mentioned | K060774, K800781 |
| Product codes mentioned | CGN, KIS, CIT, LXG, PFF, PFT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1